Literature DB >> 18006310

Azaterphenyl diamidines as antileishmanial agents.

Laixing Hu1, Reem K Arafa, Mohamed A Ismail, Tanja Wenzler, Reto Brun, Manoj Munde, W David Wilson, Sandra Nzimiro, Serene Samyesudhas, Karl A Werbovetz, David W Boykin.   

Abstract

Eighteen diamidino azaterphenyls and analogues were evaluated as anti-leishmanials; nine of the compounds gave IC50 values less than 1 microM, five exhibited values less than 0.40 microM, and two gave values less than 0.10 microM in a Leishmania donovani axenic amastigote assay. The activity of the diamidines strongly depends on the ring N-atom location relative to the amidine groups and correlates with DNA affinity. Transmission electron microscopy studies showed a dramatic dilation of the mitochondrion and evidence of disintegration of the kinetoplast of the amastigotes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006310     DOI: 10.1016/j.bmcl.2007.10.091

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

2.  Synthesis and antiprotozoal activity of dicationic 2,6-diphenylpyrazines and aza-analogues.

Authors:  Laixing Hu; Alpa Patel; Lavanya Bondada; Sihyung Yang; Michael Zhuo Wang; Manoj Munde; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Bioorg Med Chem       Date:  2013-08-13       Impact factor: 3.641

Review 3.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

4.  Synthesis and activity of azaterphenyl diamidines against Trypanosoma brucei rhodesiense and Plasmodium falciparum.

Authors:  Laixing Hu; Reem K Arafa; Mohamed A Ismail; Alpa Patel; Manoj Munde; W David Wilson; Tanja Wenzler; Reto Brun; David W Boykin
Journal:  Bioorg Med Chem       Date:  2009-08-07       Impact factor: 3.641

5.  Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts.

Authors:  Gyongseon Yang; Gahee Choi; Joo Hwan No
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

6.  Synthesis and antiprotozoal activity of cationic 1,4-diphenyl-1H-1,2,3-triazoles.

Authors:  Stanislav A Bakunov; Svetlana M Bakunova; Tanja Wenzler; Maedot Ghebru; Karl A Werbovetz; Reto Brun; Richard R Tidwell
Journal:  J Med Chem       Date:  2010-01-14       Impact factor: 7.446

7.  In vitro and in vivo studies of the trypanocidal activity of a diarylthiophene diamidine against Trypanosoma cruzi.

Authors:  Cristiane França da Silva; Marcos Meuser Batista; Denise da Gama Jaen Batista; Elen Mello de Souza; Patrícia Bernardino da Silva; Gabriel Melo de Oliveira; Andrea Souza Meuser; Abdur-Rafay Shareef; David W Boykin; Maria de Nazaré C Soeiro
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

8.  Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.

Authors:  Trupti Pandharkar; Xiaohua Zhu; Radhika Mathur; Jinmai Jiang; Thomas D Schmittgen; Chandrima Shaha; Karl A Werbovetz
Journal:  Antimicrob Agents Chemother       Date:  2014-06-02       Impact factor: 5.191

Review 9.  Novel amidines and analogues as promising agents against intracellular parasites: a systematic review.

Authors:  M N C Soeiro; K Werbovetz; D W Boykin; W D Wilson; M Z Wang; A Hemphill
Journal:  Parasitology       Date:  2013-04-08       Impact factor: 3.234

10.  Synthesis of new thienylpicolinamidine derivatives and possible mechanisms of antiproliferative activity.

Authors:  Mohamed A Ismail; Mohamed H Abdel-Rhman; Ghada A Abdelwahab; Wafaa S Hamama; Heba M El-Shafeai; Wael M El-Sayed
Journal:  RSC Adv       Date:  2020-11-11       Impact factor: 4.036

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.